Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) EBT: 2017-2024

Historic EBT for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $24.1 million.

  • Puma Biotechnology's EBT fell 55.15% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.9 million, marking a year-over-year increase of 25.33%. This contributed to the annual value of $24.1 million for FY2024, which is 6.29% up from last year.
  • According to the latest figures from FY2024, Puma Biotechnology's EBT is $24.1 million, which was up 6.29% from $22.7 million recorded in FY2023.
  • Puma Biotechnology's 5-year EBT high stood at $24.1 million for FY2024, and its period low was -$59.8 million during FY2020.
  • For the 3-year period, Puma Biotechnology's EBT averaged around $15.7 million, with its median value being $22.7 million (2023).
  • Data for Puma Biotechnology's EBT shows a peak YoY skyrocketed of 4,861.49% (in 2023) over the last 5 years.
  • Over the past 5 years, Puma Biotechnology's EBT (Yearly) stood at -$59.8 million in 2020, then soared by 51.83% to -$28.8 million in 2021, then surged by 101.59% to $457,000 in 2022, then skyrocketed by 4,861.49% to $22.7 million in 2023, then rose by 6.29% to $24.1 million in 2024.